Frank R. Pieper | Chief Executive Officer
Frank has over 20 years of experience in the area of biotechnology and life sciences. Trained as a molecular biologist, he has served in various senior management functions, together covering a broad spectrum of corporate development activities. These include R&D, product development, strategic planning and licensing, operations, manufacturing, business development and intellectual property management. He was involved in various financing rounds and a Euronext IPO, and has served for 10 years on the management board of Pharming Group NV.
Maurice van der Heijden | Director R&D
Maurice van der Heijden has extensive expertise in molecular and cell biology studies. After obtaining his Ph.D. in Molecular Virology from the Leiden University he held postdoctoral positions at the Leiden University and the Utrecht University. Prior to joining ProteoNic, he held a scientific position in antibody discovery at Janssen Pharmaceutical Companies.
Guido J. Kwikkers | Chief Financial Officer
Guido has a degree in business administration. He has as well rounded background in the finance, IT and legal disciplines from various international assignments. In his career he gained experience at a large multinational, leading corporate restructuring and from his involvement with setting up a new company.
Mark Posno | Director Business Development
Mark has more than 20 years of experience in global business development in the pharmaceutical and biotechnology industry. Trained as a molecular biologist, he has ample experience in translating protein production technologies into business propositions. Mark has been involved in various biotechnology companies and research institutes in the US and Europe. Located in the USA, Mark is responsible for commercial development and strategic partnerships.